CJC-1295 w/o DAC

Handling & storage

CJC-1295 w/o DAC is a synthetic growth hormone-releasing hormone (GHRH) analog supplied for controlled laboratory and analytical research. It is studied in experimental models investigating GHRH receptor activity, endocrine signaling, growth hormone-associated pathways, and peptide-receptor interactions. Unlike the DAC-modified version, CJC-1295 w/o DAC does not contain a Drug Affinity Complex. This structural distinction makes it useful in laboratory research comparing peptide stability, receptor interactions, pharmacokinetic characteristics, and signaling behavior among modified GHRH analogs. Laboratory investigations involving CJC-1295 w/o DAC may examine GHRH receptor-mediated signaling, endocrine pathway interactions, peptide structure-function relationships, cellular responses, and other mechanisms associated with growth hormone biology. These areas represent experimental research applications and should not be interpreted as established therapeutic effects. CJC-1295 w/o DAC is supplied as a lyophilized research material with batch-specific analytical documentation available for applicable manufacturing lots. Researchers should reference the corresponding Certificate of Analysis for reported identity, purity, and other available analytical specifications. For research use only. Keep lyophilized material protected from light, moisture, and temperature excursions. Follow institutional SOPs, product documentation, and the applicable Certificate of Analysis for storage, handling, preparation, and disposal. Not for human or veterinary consumption. Not intended for diagnostic, therapeutic, or clinical use.